Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Severe COVID-19 Outcomes (PRESCO)

NCT04388813 is registered in ClinicalTrials.gov with Verily Life Sciences LLC as lead sponsor.

NCT NCT04388813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04388813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Severe COVID-19 Outcomes (PRESCO)
Lead sponsor
Verily Life Sciences LLC
Phase
Observational
Overall status
Completed
Start date
May 28, 2020
Completion date
September 23, 2021
Enrollment
494 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid-19